Scleroderma Treatment With Autologous Transplant (STAT) Study

Conditions

• Systemic Scleroderma

Interventions

• BIOLOGICAL: Anti-Thymocyte Globulin
• PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
• DRUG: Cyclophosphamide
• BIOLOGICAL: Filgrastim
• OTHER: Laboratory Biomarker Analysis
• DRUG: Mycophenolate Mofetil
• PROCEDURE: Peripheral Blood Stem Cell Transplantation
• DRUG: Plerixafor
• OTHER: Quality-of-Life Assessment
• OTHER: Questionnaire Administration

Sponsor

Fred Hutchinson Cancer Center

Collaborators

• [object Object]